165 related articles for article (PubMed ID: 20951169)
1. Cellular FLIP(L) plays a survival role and regulates morphogenesis in breast epithelial cells.
Yerbes R; Palacios C; Reginato MJ; López-Rivas A
Biochim Biophys Acta; 2011 Jan; 1813(1):168-78. PubMed ID: 20951169
[TBL] [Abstract][Full Text] [Related]
2. α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.
Yu W; Tiwary R; Li J; Park SK; Jia L; Xiong A; Simmons-Menchaca M; Sanders BG; Kline K
Mol Carcinog; 2010 Nov; 49(11):964-73. PubMed ID: 20886583
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
[TBL] [Abstract][Full Text] [Related]
4. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.
Day TW; Huang S; Safa AR
Biochem Pharmacol; 2008 Dec; 76(12):1694-704. PubMed ID: 18840411
[TBL] [Abstract][Full Text] [Related]
5. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
7. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins.
Lee SJ; Noh HJ; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Int J Oncol; 2011 Feb; 38(2):485-92. PubMed ID: 21170508
[TBL] [Abstract][Full Text] [Related]
8. Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing.
Wilson TR; Redmond KM; McLaughlin KM; Crawford N; Gately K; O'Byrne K; Le-Clorrenec C; Holohan C; Fennell DA; Johnston PG; Longley DB
Cell Death Differ; 2009 Oct; 16(10):1352-61. PubMed ID: 19543235
[TBL] [Abstract][Full Text] [Related]
9. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
10. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells.
Palacios C; Yerbes R; López-Rivas A
Cancer Res; 2006 Sep; 66(17):8858-69. PubMed ID: 16951203
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
12. Calyculin A causes sensitization to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by ROS-mediated down-regulation of cellular FLICE-inhibiting protein (c-FLIP) and by enhancing death receptor 4 mRNA stabilization.
Woo SM; Min KJ; Kwon TK
Apoptosis; 2012 Nov; 17(11):1223-34. PubMed ID: 22911475
[TBL] [Abstract][Full Text] [Related]
13. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
Nastiuk KL; Yoo K; Lo K; Su K; Yeung P; Kutaka J; Danielpour D; Krolewski JJ
Mol Cancer Res; 2008 Feb; 6(2):231-42. PubMed ID: 18314484
[TBL] [Abstract][Full Text] [Related]
14. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
[TBL] [Abstract][Full Text] [Related]
16. ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2.
Martín-Pérez R; Niwa M; López-Rivas A
Apoptosis; 2012 Apr; 17(4):349-63. PubMed ID: 22072062
[TBL] [Abstract][Full Text] [Related]
17. Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8.
Chacko AD; Liberante F; Paul I; Longley DB; Fennell DA
BMC Cancer; 2010 Jul; 10():380. PubMed ID: 20646307
[TBL] [Abstract][Full Text] [Related]
18. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM
J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432
[TBL] [Abstract][Full Text] [Related]
19. Control of FLIP(L) expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells.
Yerbes R; López-Rivas A; Reginato MJ; Palacios C
Cell Death Differ; 2012 Dec; 19(12):1908-16. PubMed ID: 22722337
[TBL] [Abstract][Full Text] [Related]
20. The SCF
Roberts JZ; Holohan C; Sessler T; Fox J; Crawford N; Riley JS; Khawaja H; Majkut J; Evergren E; Humphreys LM; Ferris J; Higgins C; Espona-Fiedler M; Moynagh P; McDade SS; Longley DB
Cell Death Differ; 2020 Sep; 27(9):2726-2741. PubMed ID: 32313199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
